ATE307133T1 - Hexahydroazepino(4,5-g)indole und -indoline als 5-ht-rezeptor-liganden - Google Patents

Hexahydroazepino(4,5-g)indole und -indoline als 5-ht-rezeptor-liganden

Info

Publication number
ATE307133T1
ATE307133T1 AT02744532T AT02744532T ATE307133T1 AT E307133 T1 ATE307133 T1 AT E307133T1 AT 02744532 T AT02744532 T AT 02744532T AT 02744532 T AT02744532 T AT 02744532T AT E307133 T1 ATE307133 T1 AT E307133T1
Authority
AT
Austria
Prior art keywords
sup
hexahydroazepino
indolines
indoles
receptor ligands
Prior art date
Application number
AT02744532T
Other languages
English (en)
Inventor
Jian-Min Fu
Jeanette Kay Morris
Arthur Glenn Romero
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE307133T1 publication Critical patent/ATE307133T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02744532T 2001-07-13 2002-07-10 Hexahydroazepino(4,5-g)indole und -indoline als 5-ht-rezeptor-liganden ATE307133T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30530501P 2001-07-13 2001-07-13
PCT/US2002/019804 WO2003006466A1 (en) 2001-07-13 2002-07-10 Hexahydroazepino (4, 5-g) indoles and indolines as 5-ht receptor ligands

Publications (1)

Publication Number Publication Date
ATE307133T1 true ATE307133T1 (de) 2005-11-15

Family

ID=23180257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02744532T ATE307133T1 (de) 2001-07-13 2002-07-10 Hexahydroazepino(4,5-g)indole und -indoline als 5-ht-rezeptor-liganden

Country Status (11)

Country Link
US (1) US7022694B2 (de)
EP (1) EP1406902B1 (de)
JP (1) JP2005522408A (de)
AT (1) ATE307133T1 (de)
BR (1) BR0211140A (de)
CA (1) CA2452610A1 (de)
DE (1) DE60206762T2 (de)
DK (1) DK1406902T3 (de)
ES (1) ES2250667T3 (de)
MX (1) MXPA04000358A (de)
WO (1) WO2003006466A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003256793A1 (en) * 2002-08-20 2004-03-11 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
DE60321354D1 (de) * 2002-08-29 2008-07-10 Schering Corp Selektive d1/d5 rezeptorantagonisten zur behandlung von fettleibigkeit und von zns störungen
SI1720836T1 (sl) 2004-02-25 2014-06-30 Eli Lilly And Company 6-substituirani 2,3,4,5-tetrahidro-1h-benzo (d)azepini kot agonisti 5-ht2c receptorja
JP5173190B2 (ja) 2004-08-25 2013-03-27 武田薬品工業株式会社 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
CN101253153A (zh) 2005-09-01 2008-08-27 伊莱利利公司 作为5－HT<sub>2c</sub>受体激动剂的6－取代的2,3,4,5－四氢－1H－苯并[d]氮杂䓬
CA2619450C (en) 2005-09-01 2013-10-22 Eli Lilly And Company 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
ATE438627T1 (de) 2005-09-01 2009-08-15 Lilly Co Eli 6-substituierte- 2,3,4,5-tetrahydro-1h- benzoädüazepine als 5-ht2c-rezeptoragonisten
AU2006287202B2 (en) 2005-09-01 2013-01-24 Eli Lilly And Company 6-arylalkylamino- 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2c receptor agonists
EP2727585A1 (de) 2006-05-16 2014-05-07 Takeda Pharmaceutical Company Limited In-vivo Screening-Methode
EP2789338A3 (de) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Kondensiertes Pyridinderivat und seine Verwendung
EP2510949A4 (de) 2009-12-11 2013-11-13 Astellas Pharma Inc Therapeutikum für fibromyalgie
CA2947300A1 (en) 2014-05-05 2015-11-12 Zhengbing Cao Antimicrobial surface coatings
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces
EP3753924A1 (de) * 2019-06-18 2020-12-23 AnaMar AB Neue tricyclische 5-ht2-antagonisten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK26793D0 (da) 1993-03-10 1993-03-10 Novo Nordisk As Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling
AU687255B2 (en) 1994-09-14 1998-02-19 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives, their preparation and use
UA54403C2 (uk) 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
EP0973778A1 (de) 1997-03-07 2000-01-26 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3,2-c]pyridin-derivate ihre herstellung und ihre verwendung
EP1066037B1 (de) 1998-03-31 2004-12-29 Neurosearch A/S Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi

Also Published As

Publication number Publication date
WO2003006466A1 (en) 2003-01-23
US7022694B2 (en) 2006-04-04
ES2250667T3 (es) 2006-04-16
CA2452610A1 (en) 2003-01-23
EP1406902B1 (de) 2005-10-19
EP1406902A1 (de) 2004-04-14
JP2005522408A (ja) 2005-07-28
DE60206762D1 (de) 2006-03-02
DE60206762T2 (de) 2006-07-13
DK1406902T3 (da) 2006-01-30
BR0211140A (pt) 2005-10-25
MXPA04000358A (es) 2004-05-04
US20030060458A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
ATE307133T1 (de) Hexahydroazepino(4,5-g)indole und -indoline als 5-ht-rezeptor-liganden
ATE302771T1 (de) Indolinon-derivative als protein-kinasehemmer
MY143367A (en) Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
EA200301213A1 (ru) Лиганды рецепторов 5-ht и их применение
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
MY144483A (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
DE60021282D1 (de) Carbamat-derivate als muscarin-rezeptor antonisten
WO2004048330A8 (en) N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
EA200602196A1 (ru) Производные пиразола, композиции, содержащие эти соединения, и способы применения
AU9102198A (en) Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
NO20061845L (no) Fenyl-piperazinderivater som modulatorer for muskarine reseptorer
MXPA04001089A (es) 5-arilsulfonil indoles que tienen afinidad por el receptor de 5-ht.
ATE417838T1 (de) Arylsulfonyl-derivate mit 5-ht 6-rezeptor- affinität
ATE315563T1 (de) Piperidinylmorpholinylderivate als modulatoren der aktivität des chemokinrezeptors
DE60327375D1 (de) Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten
MX2008002539A (es) Derivados de (indol-3-il)-heterociclo como agonistas del receptor canabinoide cb1.
ATE406363T1 (de) Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten
ATE337781T1 (de) Pyridinalykl-aminoalkyl-1h-indol derivate mit hemmender wirkung auf die 5-ht und serotonin wiederaufnahme als antidepressiva und anxiolytika
MXPA05013256A (es) Derivados de 1-(alquilaminoalquil-pirolidin-/piperidinil) -2,2-difenilacetamida como antagonistas de receptores muscarinicos.
IL188927A0 (en) Aryloxy quinolines and uses thereof as 5-ht6 modulators
WO2003076426A3 (en) Pyridinyloxy derivatives as 5-ht receptor ligands
MXPA04001201A (es) Derivados tetraciclicos de indol como ligandos del receptor de 5-ht.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1406902

Country of ref document: EP

REN Ceased due to non-payment of the annual fee